ImmuCell Corporation (ICCC) vs ProMIS Neurosciences, Inc. (PMN)
A side-by-side comparison of ImmuCell Corporation and ProMIS Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ICCC
ImmuCell Corporation
$9.75HealthcareDelayed quote: Oct 6, 2026, 2:29 PM EDT
PMN
ProMIS Neurosciences, Inc.
$9.11HealthcareDelayed quote: Oct 6, 2026, 2:35 PM EDT
Total return — ICCC vs PMN
growth of $100 · dividends reinvested · last 10yICCC +26.0% (+2.3%/yr)PMN -93.8% (-24.2%/yr)ICCC compounded faster over this window
Log scale — wide-divergence pair
ICCC PMN
ICCC vs PMN: by the numbers
- •ICCC is the larger company ($88M vs $82M market cap).
- •ICCC is profitable (2.57% net margin) while PMN runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ICCC | PMN |
|---|---|---|
| P/E ratio | 115.25 | N/A |
| P/S ratio | 2.88 | N/A |
| P/B ratio | 2.81 | 1.65 |
| EV / EBITDA | 14.69 | N/A |
| FCF yield | 4.78% | N/A |
Profitability
| Metric | ICCC | PMN |
|---|---|---|
| Gross margin | 40.32% | 0.00% |
| Operating margin | 12.60% | 0.00% |
| Net margin | 2.57% | 0.00% |
| ROE | 2.51% | -85.48% |
| ROIC | 8.16% | -87.79% |
Growth (annualized)
| Metric | ICCC | PMN |
|---|---|---|
| Revenue CAGR (5Y) | 13.74% | N/A |
| Total return CAGR (5Y) | 0.65% | -47.05% |
Frequently asked
- Is ICCC or PMN more profitable?
- ICCC runs the higher net margin — ICCC at 2.57% versus PMN at 0.00%.
- How have ICCC and PMN total returns compared?
- Over the past 10 years, ICCC delivered 2.46% and PMN delivered -22.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ImmuCell P/E ratioImmuCell ROEProMIS Neurosciences ROEImmuCell operating marginProMIS Neurosciences operating marginImmuCell revenue growthProMIS Neurosciences revenue growthImmuCell free cash flowProMIS Neurosciences free cash flow
ImmuCell & ProMIS Neurosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.